Related Experiment Videos
Heritability heightens brain metabolite differences in schizophrenia
1Department of Neuropsychiatry, Faculty of Medicine, Kagoshima University, Japan. fukuzako@med4.kufm.kagoshima-u.ac.jp
Summary
Medicated schizophrenic patients exhibit reduced N-acetylaspartate/creatine-phosphocreatine ratios in the medial temporal lobe. This neurochemical difference, detectable via magnetic resonance spectroscopy, was more pronounced in those with a family history of psychosis.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Schizophrenia is a complex psychiatric disorder with suspected neurobiological underpinnings.
- Alterations in brain metabolism and neurochemistry are increasingly investigated as potential biomarkers.
- The medial temporal lobe plays a crucial role in memory and emotion, areas often affected in schizophrenia.
Purpose of the Study:
- To investigate neurochemical differences in the medial temporal lobe of medicated schizophrenic patients compared to healthy controls.
- To explore the relationship between these neurochemical differences and a family history of psychotic disorders.
Main Methods:
- Single-voxel proton magnetic resonance spectroscopy (MRS) was utilized.
- Spectra were acquired from a standardized voxel in the left medial temporal lobe.
- A 2.0-tesla whole-body magnetic resonance imaging (MRI) system was employed for data acquisition.
Main Results:
- Schizophrenic patients demonstrated a significantly lower N-acetylaspartate/creatine-phosphocreatine (NAA/Cr) ratio compared to healthy subjects.
- This reduction in the NAA/Cr ratio was more pronounced in schizophrenic patients with a documented family history of psychotic disorders.
- The findings suggest metabolic alterations within the medial temporal lobe in schizophrenia.
Conclusions:
- Proton magnetic resonance spectroscopy can detect specific neurochemical alterations in the medial temporal lobe of medicated schizophrenic patients.
- The observed NAA/Cr ratio reduction may serve as a potential imaging biomarker for schizophrenia.
- Family history of psychosis is associated with more significant metabolic changes in this brain region, suggesting a potential genetic influence on neurochemistry.